These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35022385)

  • 1. Connexin 43 confers chemoresistance through activating PI3K.
    Pridham KJ; Shah F; Hutchings KR; Sheng KL; Guo S; Liu M; Kanabur P; Lamouille S; Lewis G; Morales M; Jourdan J; Grek CL; Ghatnekar GG; Varghese R; Kelly DF; Gourdie RG; Sheng Z
    Oncogenesis; 2022 Jan; 11(1):2. PubMed ID: 35022385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3CB/p110β is a selective survival factor for glioblastoma.
    Pridham KJ; Le L; Guo S; Varghese RT; Algino S; Liang Y; Fajardin R; Rodgers CM; Simonds GR; Kelly DF; Sheng Z
    Neuro Oncol; 2018 Mar; 20(4):494-505. PubMed ID: 29016844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.
    Murphy SF; Varghese RT; Lamouille S; Guo S; Pridham KJ; Kanabur P; Osimani AM; Sharma S; Jourdan J; Rodgers CM; Simonds GR; Gourdie RG; Sheng Z
    Cancer Res; 2016 Jan; 76(1):139-49. PubMed ID: 26542214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta.
    Pridham KJ; Hutchings KR; Beck P; Liu M; Xu E; Saechin E; Bui V; Patel C; Solis J; Huang L; Tegge A; Kelly DF; Sheng Z
    iScience; 2024 Jun; 27(6):109921. PubMed ID: 38812542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.
    Pridham KJ; Varghese RT; Sheng Z
    Front Oncol; 2017; 7():312. PubMed ID: 29326882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation.
    Karlsson T; Krakstad C; Tangen IL; Hoivik EA; Pollock PM; Salvesen HB; Lewis AE
    Oncotarget; 2017 Jan; 8(3):3881-3894. PubMed ID: 28002804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.
    Huang BR; Tsai CH; Chen CC; Way TD; Kao JY; Liu YS; Lin HY; Lai SW; Lu DY
    Am J Chin Med; 2019; 47(3):657-674. PubMed ID: 30974966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of α Carboxyl Terminus 1 Peptide With the Connexin 43 Carboxyl Terminus Preserves Left Ventricular Function After Ischemia-Reperfusion Injury.
    Jiang J; Hoagland D; Palatinus JA; He H; Iyyathurai J; Jourdan LJ; Bultynck G; Wang Z; Zhang Z; Schey K; Poelzing S; McGowan FX; Gourdie RG
    J Am Heart Assoc; 2019 Aug; 8(16):e012385. PubMed ID: 31422747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury.
    O'Quinn MP; Palatinus JA; Harris BS; Hewett KW; Gourdie RG
    Circ Res; 2011 Mar; 108(6):704-15. PubMed ID: 21273554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β.
    Nakanishi Y; Walter K; Spoerke JM; O'Brien C; Huw LY; Hampton GM; Lackner MR
    Cancer Res; 2016 Mar; 76(5):1193-203. PubMed ID: 26759240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
    Gielen PR; Aftab Q; Ma N; Chen VC; Hong X; Lozinsky S; Naus CC; Sin WC
    Neuropharmacology; 2013 Dec; 75():539-48. PubMed ID: 23688923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43.
    Munoz JL; Rodriguez-Cruz V; Greco SJ; Ramkissoon SH; Ligon KL; Rameshwar P
    Cell Death Dis; 2014 Mar; 5(3):e1145. PubMed ID: 24675463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo.
    Pu P; Kang C; Zhang Z; Liu X; Jiang H
    Technol Cancer Res Treat; 2006 Jun; 5(3):271-80. PubMed ID: 16700623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
    Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
    J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling.
    Xia X; Batra N; Shi Q; Bonewald LF; Sprague E; Jiang JX
    Mol Cell Biol; 2010 Jan; 30(1):206-19. PubMed ID: 19841066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide.
    Yang ZJ; Zhang LL; Bi QC; Gan LJ; Wei MJ; Hong T; Tan RJ; Lan XM; Liu LH; Han XJ; Jiang LP
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of a novel somatic oncogenic mutation of
    Whale AD; Colman L; Lensun L; Rogers HL; Shuttleworth SJ
    Signal Transduct Target Ther; 2017; 2():17063. PubMed ID: 29279775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gap junction connexins in female reproductive organs: implications for women's reproductive health.
    Winterhager E; Kidder GM
    Hum Reprod Update; 2015; 21(3):340-52. PubMed ID: 25667189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
    Crowder RJ; Phommaly C; Tao Y; Hoog J; Luo J; Perou CM; Parker JS; Miller MA; Huntsman DG; Lin L; Snider J; Davies SR; Olson JA; Watson MA; Saporita A; Weber JD; Ellis MJ
    Cancer Res; 2009 May; 69(9):3955-62. PubMed ID: 19366795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.
    Mateo J; Ganji G; Lemech C; Burris HA; Han SW; Swales K; Decordova S; DeYoung MP; Smith DA; Kalyana-Sundaram S; Wu J; Motwani M; Kumar R; Tolson JM; Rha SY; Chung HC; Eder JP; Sharma S; Bang YJ; Infante JR; Yan L; de Bono JS; Arkenau HT
    Clin Cancer Res; 2017 Oct; 23(19):5981-5992. PubMed ID: 28645941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.